The Iconic American Brands Are No Longer American

In 2012, Concord Medical from Beijing made headlines by purchasing a 20% stake in the University of Texas M.D. Anderson Cancer Center Proton Therapy Center, enhancing its reputation without affecting the University’s ownership.

Dr. Jianyu Yang, CEO of Concord Medical, asserts the significance of proton treatment in radiation therapy. The company aims to utilize this strategic partnership to learn from the premier entity in proton therapy, planning two new centers in China.